The crosstalk between adenosine A2B receptor and insulin signalling in rat skeletal muscle cells

Habahbeh, Suna and Imraish, Amer and Zihlif, Malek (2020) The crosstalk between adenosine A2B receptor and insulin signalling in rat skeletal muscle cells. BIOLOGIA FUTURA, 71 (3). pp. 283-288. ISSN 2676-8615 (print); 2676-8607 (online)

Text s42977-020-00035-3.pdf Restricted to Repository staff only Download (1MB)

Abstract

Diabetes mellitus (DM) is a group of metabolic diseases characterised by hyperglycaemia resulting from defects in insulin secretion, insulin action, or both. Insulin therapy might be affected by specific metabolic enzymes and transporters. There are conflicting reports in the literature on the role of adenosine receptor A2B (AR2B) in skeletal and cardiac muscle glucose metabolism. This study aims to find out if there is an association between AR2B and insulin signalling, especially the metabolic pathways (AKT-GSK). Differentiated L6 cell rat muscle cells were treated with insulin, adenosine agonist NECA, selective AR2B antagonist PSB 603 and combinations between these reagents, the expression of AKT2, GSK3α, and GSK3β were measured by qPCR hydrolysis probe technique. Insulin increases AKT2, GSK3α and GSK3β mRNA expression, while AR2B antagonist inhibits AKT2 GSK3α and GSK3β mRNA expression and combining AR2B antagonist with insulin diminish insulin action and decrease AKT2 GSK3α and GSK3β mRNA expression, which means a strong relationship between AR2B and insulin action. Furthermore AR2B agonist may be a good candidate as an anti-diabetic drug.

Actions (login required)

Edit Item